Abstract

Muscle function is compromised by gravitational unloading in space affecting overall musculoskeletal health. Astronauts perform daily exercise programmes to mitigate these effects but knowing which muscles to target would optimise effectiveness. Accurate inflight assessment to inform exercise programmes is critical due to lack of technologies suitable for spaceflight. Changes in mechanical properties indicate muscle health status and can be measured rapidly and non-invasively using novel technology. A hand-held MyotonPRO device enabled monitoring of muscle health for the first time in spaceflight (> 180 days). Greater/maintained stiffness indicated countermeasures were effective. Tissue stiffness was preserved in the majority of muscles (neck, shoulder, back, thigh) but Tibialis Anterior (foot lever muscle) stiffness decreased inflight vs. preflight (p < 0.0001; mean difference 149 N/m) in all 12 crewmembers. The calf muscles showed opposing effects, Gastrocnemius increasing in stiffness Soleus decreasing. Selective stiffness decrements indicate lack of preservation despite daily inflight countermeasures. This calls for more targeted exercises for lower leg muscles with vital roles as ankle joint stabilizers and in gait. Muscle stiffness is a digital biomarker for risk monitoring during future planetary explorations (Moon, Mars), for healthcare management in challenging environments or clinical disorders in people on Earth, to enable effective tailored exercise programmes.

Details

Title
Muscle stiffness indicating mission crew health in space
Author
Schoenrock, Britt 1 ; Muckelt, Paul E. 2 ; Hastermann, Maria 3 ; Albracht, Kirsten 4 ; MacGregor, Robert 5 ; Martin, David 6 ; Gunga, Hans-Christian 7 ; Salanova, Michele 1 ; Stokes, Maria J. 2 ; Warner, Martin B. 2 ; Blottner, Dieter 1   VIAFID ORCID Logo 

 Institute of Integrative Neuroanatomy, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115 Berlin, Germany, NeuroMuscular System & Signaling Group, Berlin Center of Space Medicine and Extreme Environments, 10115 Berlin, Germany, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639) 
 University of Southampton, School of Health Sciences, Southampton, UK (GRID:grid.5491.9) (ISNI:0000 0004 1936 9297) 
 Charité - Universitätsmedizin Berlin, Experimental and Clinical Research Center (ECRC) and NeuroCure Clinical Research Center (NCRC), Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662) 
 Aachen University of Applied Sciences, Aachen, Germany (GRID:grid.434081.a) (ISNI:0000 0001 0698 0538) 
 Airbus US Space & Defense Inc. at JSC, Houston, USA (GRID:grid.434081.a) 
 JSC-SK KBR Wyle Services, Houston, USA (GRID:grid.419085.1) (ISNI:0000 0004 0613 2864) 
 Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10115 Berlin, Germany, Institute of Physiology, Berlin Center of Space Medicine and Extreme Environments, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639) 
Pages
4196
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2928723872
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.